Oryzon Genomics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 23, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	248	91	115	133	142	210
Market Cap Growth	137.36%	-21.18%	-13.63%	-6.58%	-32.20%	66.16%
Enterprise Value	235	99	121	129	124	180
Last Close Price	3.08	1.50	1.93	2.60	2.62	3.46
PS Ratio	33.65	12.31	8.10	8.48	13.42	22.07
PB Ratio	-	1.04	1.41	1.83	2.00	2.77
P/TBV Ratio	-	1.04	1.41	1.85	2.02	2.78
EV/Sales Ratio	31.88	13.40	8.53	8.19	11.66	18.92
Debt / Equity Ratio	-	0.19	0.22	0.31	0.25	0.18
Net Debt / Equity Ratio	-	0.12	0.07	0.02	-0.16	-0.34
Net Debt / EBITDA Ratio	-	-2.42	-1.36	-0.23	1.63	6.27
Net Debt / FCF Ratio	-	-1.86	-10.46	-0.64	2.95	5.25
Asset Turnover	-	0.07	0.14	0.16	0.11	0.11
Inventory Turnover	-	67.11	30.80	8.17	3.55	1.74
Quick Ratio	-	0.74	0.87	1.34	3.75	5.47
Current Ratio	-	0.75	0.87	1.34	3.76	5.51
Return on Equity (ROE)	-	-4.34%	-4.35%	-5.88%	-6.37%	-4.96%
Return on Assets (ROA)	-	-2.61%	-2.71%	-3.45%	-4.63%	-3.08%
Return on Invested Capital (ROIC)	-14.59%	-4.71%	-5.73%	-7.98%	-12.34%	-10.01%
Return on Capital Employed (ROCE)	-	-4.60%	-5.00%	-6.50%	-8.10%	-5.00%
Earnings Yield	-1.11%	-4.05%	-2.92%	-3.18%	-3.29%	-1.62%
FCF Yield	-	-6.28%	-0.50%	-1.44%	-2.67%	-2.37%
Buyback Yield / Dilution	-18.64%	-6.35%	-10.10%	-4.80%	-	-15.99%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.